You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Claims for Patent: 9,486,588


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,486,588
Title:Automatic injection device with reset feature
Abstract:The present invention relates to a dose setting and expelling device comprising a drive member and a dose setting mechanism which simultaneously sets a given dose and stores the energy necessary for a subsequently driving the drive member in order to expel a dose of medicine from an injection device. According to the invention the dose setting mechanism allows adjustment in both directions, such that a given set dose can be reduced or cancelled by reversing the input motion, typically by rotating a setting member backwardly, this in contrast to the known devices which either requires an additional release mechanism or which cannot be reversed at all.
Inventor(s):Christian Peter Enggaard
Assignee: Novo Nordisk AS
Application Number:US14/168,700

Details for Patent 9,486,588

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novo Nordisk Inc. LEVEMIR insulin detemir Injection 021536 June 16, 2005 ⤷  Get Started Free 2034-01-30
Novo Nordisk Inc. LEVEMIR insulin detemir Injection 021536 October 31, 2013 ⤷  Get Started Free 2034-01-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 9,486,588

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 02053214 ⤷  Get Started Free
United States of America 8672898 ⤷  Get Started Free
United States of America 6899699 ⤷  Get Started Free
United States of America 2015025471 ⤷  Get Started Free
United States of America 2005055011 ⤷  Get Started Free
United States of America 2002120235 ⤷  Get Started Free
Portugal 1351732 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.